Intellect Neurosciences Files Appeal in Europe in Response to Opposition Proceedings Instituted by Elan Pharmaceuticals and Wy... ( NEW YORK Dec. 15 2011 /- Intellect Ne...)

Navigation Links

Biology News Medicine News Biology Products Medicine Products Biology Definition Medicine Definition Biology Technology Medicine Technology Biology Dictionary Medicine Dictionary

HOME >> MEDICINE >> TECHNOLOGY

Intellect Neurosciences Files Appeal in Europe in Response to Opposition Proceedings Instituted by Elan Pharmaceuticals and Wyeth/Pfizer

Date:12/15/2011

NEW YORK, Dec. 15, 2011 /PRNewswire/ -- Intellect Neurosciences, Inc. (OTCBB: ILNS), a biopharmaceutical company engaged in the discovery and development of disease-modifying therapeutic agents for the treatment of Alzheimer's and other neurological diseases announced today that it has filed an appeal regarding a preliminary decision of the European Patent Office (EPO) to revoke the company's ANTISENILIN® patents. The preliminary decision of the EPO resulted from a challenge by major pharmaceutical companies that are co-developing Bapineuzumab, which is in Phase 3 clinical trials for Alzheimer's disease. Intellect has ANTISENILIN® patents pending in the United States and has been granted patents in Japan, China and several other countries. None of the patents granted outside Europe were challenged.

(Logo: http://photos.prnewswire.com/prnh/20111214/NY22484LOGO )

"We are quite disappointed by actions taken by Elan Pharmaceuticals and Wyeth as well as by the preliminary decision of the EPO during Oral Proceedings in The Hague in July. We are appealing that decision and remain confident regarding our ability to prevail at the level of the Appeals Board in Munich, Germany," said Daniel Chain, chairman and CEO of Intellect Neurosciences. "Importantly, Intellect's patents remain in force in key European countries pending the outcome of the appeal process. Moreover, Intellect has filed divisional patent applications, which we believe will result in robust new patents in Europe that should be resistant to challenge and will cover products currently in clinical development. The company has excellent representation in the US and Europe where it works with premier patent firms. We remain committed to maintaining and enforcing patent protection for our inventions and product candidates."

About Intellect Neurosciences, Inc.'/>"/>

SOURCE Intellect Neurosciences, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3
Related medicine technology :

1. Intellect Neurosciences, Inc. to Present at OneMedForum
2. Ampio Pharmaceuticals Awarded European Patent that Strengthens Intellectual Property Protection for its key drug Ampion™
3. Intellect Neurosciences Obtains Two New Patents in Japan for Its Alzheimers Immunotherapy Programs
4. Intellect Neurosciences Responds to Official Action by United States Patent and Trademark Office in Relation to its ANTISENILIN® Alzheimers Patent Application
5. Intellect Neurosciences Announces Its New CONJUMAB-A Platform Technology for Novel Treatments of Alzheimers Disease and Other Proteinopathies
6. Intellect Neurosciences Issues Letter to Shareholders
7. Intellect Neurosciences CEO to be Featured on Wall Street Reporter
8. ViroPharma Licenses Rights From Intellect Neurosciences for Product Candidate for Friedreichs Ataxia
9. IRIDEX Licenses the Exclusive Rights to Ophthalmology Products and Intellectual Property from Ocunetics, Inc.
10. PILMA Vows to Redouble Support for Increased Protections Against Intellectual Property Theft
11. Dehaier Strengthens Intellectual Property Portfolio

Post Your Comments:

(Date:5/23/2013)... DIEGO y PARÍS, 24 de mayo ... VOLC ), un destacado desarrollador y fabricante de ... mejorar la diagnosis y tratamiento de la enfermedad ... preliminares del ensayo ADVISE ( Ad enosine ... E valuation) II durante la sesión de ...

(Date:5/23/2013)... May 23, 2013 Amgen (NASDAQ: AMGN ... Annual Healthcare Conference on Thursday, May 30, 2013, at the ... at 9:20 a.m. Eastern Daylight Time. Arvind Sood ... present at the conference. Live audio of the presentation can ... www.amgen.com , under Investors. A replay of the webcast will ...

(Date:5/23/2013)... Nephros, Inc. (OTC Bulletin Board: ... develops and sells high performance liquid purification ultrafilters, announced ... addition, the concurrent temporary reduction in exercise price for ... 2013. Nephros estimates that it will receive ... A portion of the proceeds will be used for ...

Breaking Medicine Technology:Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 2 Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 3 Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 4 Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 5 Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 6 Nephros Announces Completion of Rights Offering 2 Nephros Announces Completion of Rights Offering 3 Nephros Announces Completion of Rights Offering 4

[0] Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 [0] Amgen to Present at the Deutsche Bank 38th Annual Healthcare Conference [0] Nephros Announces Completion of Rights Offering

... 13, 2011 /PRNewswire-Asia-FirstCall/ -- China Sky One Medical, Inc. ... CSKI ), a leading fully integrated pharmaceutical company ... ("PRC"), today announced that it held its 2011 Annual ... 2011, in Harbin, PRC. At the Annual ...

... 2011 /PRNewswire-Asia-FirstCall/ -- China Medical Technologies, Inc. (the "Company") ... in-vitro diagnostic ("IVD") company, today announced that China,s State ... Company,s real-time PCR-based V-Ki-ras2 Kirsten rat sarcoma viral oncogene ... companion diagnostic test for the use of a targeted ...

Cached Medicine Technology:China Sky One Medical, Inc. Elects Board Directors at its Annual Shareholders Meeting 2 China Medical Technologies Receives SFDA Approval for its PCR-based KRAS Assay for Colorectal Cancer Targeted Drug 2

China Sky One Medical, Inc. Elects Board Directors at its Annual Shareholders Meeting China Medical Technologies Receives SFDA Approval for its PCR-based KRAS Assay for Colorectal Cancer Targeted Drug

(Date:5/23/2013)... 23, 2013 Today, Zane Benefits, Inc. ... . Zane Benefits, which provides comprehensive and flexible alternatives ... in defined contribution plans and health ... common question from employees is “does my employer have ... not necessarily. The health care reform law, called the ...

(Date:5/23/2013)... 2013 Da Vinci surgical robot maker ... in Washington State May 23, according to Bloomberg.* The ... surgical robot lawsuits , expresses disappointment in the ruling ... to not read a single verdict as representative of ... Fred E. Taylor v. Intuitive Surgical Inc.; 09-2-03136-5, Superior ...

(Date:5/23/2013)... modified version of the polio virus might one ... Scientists at Duke Cancer Institute said the ... engineered form of the virus that is harmless ... therapy shows promise in the treatment of glioblastoma, ... said. "These early results are intriguing," principal ...

(Date:5/23/2013)... Ohio (May 23, 2013)Don,t doubt it when a woman ... time remembering things. A new study published online in ... Menopause Society (NAMS), helps confirm with objective tests that ... , In the past, some studies showed that hot ... Other studies showed that, even though there was a ...

(Date:5/23/2013)... May 23, 2013 Susquehanna Health ... offering a comprehensive babysitting training course for adolescents age ... developed by Indianapolis pediatrician Dr. Patricia Keener after a ... of an adult sitter who didn’t know how to ... development program with a medical basis that aims to ...

Breaking Medicine News(10 mins):Health News:Zane Benefits Publishes New Information on the Employer Mandate 2 Health News:Zane Benefits Publishes New Information on the Employer Mandate 3 Health News:Da Vinci Surgical Robot Lawsuit News: Rottenstein Law Group LLP Comments on Intuitive Win in Negligent Training Trial 2 Health News:Modified Polio Virus May Help Fight Brain Tumors, Study Suggests 2 Health News:Susquehanna Health Offers Safe Sitter Course for Tweens and Teens 2 Health News:Susquehanna Health Offers Safe Sitter Course for Tweens and Teens 3

[0] Zane Benefits Publishes New Information on the Employer Mandate [0] Da Vinci Surgical Robot Lawsuit News: Rottenstein Law Group LLP Comments on Intuitive Win in Negligent Training Trial [0] Modified Polio Virus May Help Fight Brain Tumors, Study Suggests [0] It's not your imagination: Memory gets muddled at menopause [0] Susquehanna Health Offers Safe Sitter Course for Tweens and Teens

... in GI and Endoscopy Nursing at SGNA 36th Annual ... Nurses and Associates, Inc. (SGNA) is proud to honor ... awards that recognize their dedication to the field and ... distinguished awards represent the best in GI and endoscopy ...

... MMR Information Systems, Inc. (OTC Bulletin Board: MMRF) (the ... acquired its subsidiary MyMedicalRecords, Inc. ("MMR") in January ... to license certain of the Company,s rights relating to ... proposal were not announced.In June 2007, prior to the ...

... Intermountain Medical Center in Salt Lake City believe that ... a fairly common heart rhythm disorder, and Alzheimer,s disease, ... a study presented Friday, May 15, at "Heart Rhythm ... Society in Boston, researchers unveiled findings from the study ...

... Inc. (Nasdaq: ENDO ), an innovative medical ... technologies used by urologists and interventional radiologists for tissue ... quarter ended March 31, 2009. Highlights of the ... strong margins.Total revenues for the first quarter of 2009 ...

... Top Talent in Non-Profit Sector , ... ... of the talented businesswomen in the non-profit sector, Menttium Corporation, ... 100® leadership development program. , , ,Menttium 100 Program participants ...

... "EXQ") today announced the launch of a new research grant program, ... , ... (PRWEB) May 15, 2009 -- Exiqon A/S ... research grant program, open to researchers from academic and non-profit institutions ...

SGNA Honors Outstanding Gastroenterology and Endoscopy Professionals With Nationwide Awards MMR Information Systems, Inc. Receives Licensing Proposal Involving the Company's Anti-CD20 Antibodies Study makes first connection between heart disorder and Alzheimer's disease Endocare Reports 2009 First Quarter Financial Results Menttium Offers Scholarship Award to Businesswomen Leaders Exiqon Announces New Grant Program for MicroRNA Research

... The Medtronic Diagnostic Workstation is ... your gastrointestinal function testing needs. ... by allowing you to expand ... the consistency and reliability of ...

... using multi-channel catheters with secondary sensors placed ... catheter-based pH test also provides information about ... in the stomach or proximal esophageal acid ... pulmonary symptoms. Ability to record pH simultaneously ...

... Oxoid Pylori Test is ... for the qualitative detection of ... serum as an aid in ... H. pylori. The product is ...

... The Paragon CZE 2000 Capillary ... automate clinical serum protein electrophoresis (SPE), ... (IFE/s) for fast and accurate analysis. ... almost no sample preparation and no ...

Medicine Products:

Gastrodiagnostic Workstation Digitrapper pH Recorder OXOID PYLORI TEST Paragon CZE 2000 Capillary Electrophoresis System